169 related articles for article (PubMed ID: 30686754)
1. Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation.
Lee JS; Lee H; Lee S; Kang JH; Lee SH; Kim SG; Cho ES; Kim NH; Yook JI; Kim SY
EBioMedicine; 2019 Feb; 40():184-197. PubMed ID: 30686754
[TBL] [Abstract][Full Text] [Related]
2. Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier
Buffet A; Morin A; Castro-Vega LJ; Habarou F; Lussey-Lepoutre C; Letouzé E; Lefebvre H; Guilhem I; Haissaguerre M; Raingeard I; Padilla-Girola M; Tran T; Tchara L; Bertherat J; Amar L; Ottolenghi C; Burnichon N; Gimenez-Roqueplo AP; Favier J
Cancer Res; 2018 Apr; 78(8):1914-1922. PubMed ID: 29431636
[TBL] [Abstract][Full Text] [Related]
3. Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production.
Lee JS; Choi J; Lee SH; Kang JH; Ha JS; Kim HY; Jang H; Yook JI; Kim SY
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33238375
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the mitochondrial NADH shuttle component aspartate-glutamate carrier AGC1/Aralar1 in INS-1E cells and rat islets.
Casimir M; Rubi B; Frigerio F; Chaffard G; Maechler P
Biochem J; 2009 Dec; 424(3):459-66. PubMed ID: 19764902
[TBL] [Abstract][Full Text] [Related]
5. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.
Li H; Lin PH; Gupta P; Li X; Zhao SL; Zhou X; Li Z; Wei S; Xu L; Han R; Lu J; Tan T; Yang DH; Chen ZS; Pawlik TM; Merritt RE; Ma J
Mol Cancer; 2021 Sep; 20(1):118. PubMed ID: 34521423
[TBL] [Abstract][Full Text] [Related]
6. SLC25A11 serves as a novel prognostic biomarker in liver cancer.
Pan G; Wang R; Jia S; Li Y; Jiao Y; Liu N
Sci Rep; 2020 Jun; 10(1):9871. PubMed ID: 32555317
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis.
Tandon N; Goller K; Wang F; Soibam B; Gagea M; Jain AK; Schwartz RJ; Liu Y
EBioMedicine; 2019 Dec; 50():55-66. PubMed ID: 31761621
[TBL] [Abstract][Full Text] [Related]
8. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.
Van Nostrand JL; Brisac A; Mello SS; Jacobs SB; Luong R; Attardi LD
Cancer Discov; 2015 Jun; 5(6):622-35. PubMed ID: 25813352
[TBL] [Abstract][Full Text] [Related]
9. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
Kang JH; Lee SH; Lee JS; Nam B; Seong TW; Son J; Jang H; Hong KM; Lee C; Kim SY
Oncotarget; 2016 Aug; 7(31):49397-49410. PubMed ID: 27384481
[TBL] [Abstract][Full Text] [Related]
11. Malate-aspartate shuttle inhibitor aminooxyacetic acid leads to decreased intracellular ATP levels and altered cell cycle of C6 glioma cells by inhibiting glycolysis.
Wang C; Chen H; Zhang M; Zhang J; Wei X; Ying W
Cancer Lett; 2016 Aug; 378(1):1-7. PubMed ID: 27157912
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Lee JS; Kang JH; Lee SH; Hong D; Son J; Hong KM; Song J; Kim SY
Cell Death Dis; 2016 Dec; 7(12):e2511. PubMed ID: 27929535
[TBL] [Abstract][Full Text] [Related]
13. The 2-oxoglutarate/malate carrier extends the family of mitochondrial carriers capable of fatty acid and 2,4-dinitrophenol-activated proton transport.
Žuna K; Tyschuk T; Beikbaghban T; Sternberg F; Kreiter J; Pohl EE
Acta Physiol (Oxf); 2024 Jun; 240(6):e14143. PubMed ID: 38577966
[TBL] [Abstract][Full Text] [Related]
14. KDM6B Elicits Cell Apoptosis by Promoting Nuclear Translocation of FOXO1 in Non-Small Cell Lung Cancer.
Ma J; Wang N; Zhang Y; Wang C; Ge T; Jin H; Deng X; Huo X; Gu D; Ge Z; Chu W; Jiang L; Qin W
Cell Physiol Biochem; 2015; 37(1):201-13. PubMed ID: 26303949
[TBL] [Abstract][Full Text] [Related]
15. The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading.
Baulies A; Montero J; Matías N; Insausti N; Terrones O; Basañez G; Vallejo C; Conde de La Rosa L; Martinez L; Robles D; Morales A; Abian J; Carrascal M; Machida K; Kumar DBU; Tsukamoto H; Kaplowitz N; Garcia-Ruiz C; Fernández-Checa JC
Redox Biol; 2018 Apr; 14():164-177. PubMed ID: 28942194
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase is used by cancer cells for energy metabolism.
Kang JH; Lee SH; Hong D; Lee JS; Ahn HS; Ahn JH; Seong TW; Lee CH; Jang H; Hong KM; Lee C; Lee JH; Kim SY
Exp Mol Med; 2016 Nov; 48(11):e272. PubMed ID: 27885254
[TBL] [Abstract][Full Text] [Related]
17. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO
Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Liu Z; Huang JA
Oncotarget; 2017 May; 8(19):30817-30829. PubMed ID: 28199217
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin 3 knockdown suppresses tumour growth and angiogenesis in experimental non-small cell lung cancer.
Xia H; Ma YF; Yu CH; Li YJ; Tang J; Li JB; Zhao YN; Liu Y
Exp Physiol; 2014 Jul; 99(7):974-84. PubMed ID: 24803527
[TBL] [Abstract][Full Text] [Related]
20. The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway.
Tian XP; Jin XH; Li M; Huang WJ; Xie D; Zhang JX
Mol Cancer; 2017 Apr; 16(1):74. PubMed ID: 28372542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
